MAYINGLONG PHARMACEUTICAL GROUP STOCK CO.,LTD. revenue breakdown overview

MAYINGLONG PHARMACEUTICAL GROUP STOCK CO.,LTD. revenue for the last year amounted to 3.14 B CNY, the most of which — 1.29 B CNY — came from its highest performing source at the moment, Hemorrhoid Products, the year earlier bringing 1.49 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought MAYINGLONG PHARMACEUTICAL GROUP STOCK CO.,LTD. 3.13 B CNY, and the year before that — 3.53 B CNY.